We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Center for Disease Control (CDC) Fax to Quit/Academic Detailing Grant (F2Q/EAD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00989755
Recruitment Status : Completed
First Posted : October 5, 2009
Last Update Posted : December 9, 2015
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:

The purpose of this study is to evaluate Fax to Quit (F2Q) - a strategy that links state quitlines to health care delivery systems. FQ capitalizes upon the healthcare visit as an opportunity for intervention, consistent with the finding that approximately 70% of smokers visit a primary care physician each year. Successful integration of quitlines into healthcare delivery will transform regular healthcare visits into easily implemented, cost-beneficial avenues via which smokers all across America will be routinely inducted into effective cessation intervention. F2Q will be evaluated as follows:

  1. Does F2Q increase contacts and "quality contacts," between the quitline and patients who smoke and receive health care at a participating clinic? A "quality contact" is defined as a quitline referral that results in the individual enrolling in the quitline counseling services. This aim will be assessed by measuring the rates of quitline referrals in 49 clinics before and after F2Q has been implemented.
  2. Are contact rates and enrollment rates of F2Q increased by "Enhanced Academic Detailing" at clinic sites (with enhanced academic detailing comprising ongoing training/technical assistance as well as performance feedback)?
  3. What are the features of the Fax to Quit (F2Q) and Fax to Quit plus Enhanced Academic Detailing (F2Q + EAD) interventions that key clinic personnel found helpful and easy to implement, as well as features that were unhelpful and difficult? This information will be gathered in qualitative assessments that also will identify clinic strategies and organizational features that facilitated successful implementation.
  4. What are the incremental costs of instating and sustaining F2Q and F2Q + EAD and how do these costs compare to other quitline promotional strategies (e.g., paid media, medication give-away programs)?

Condition or disease Intervention/treatment
Smoking Other: Fax to Quit (F2Q)

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 49 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: An Evaluation of the Fax to Quit Program and Wisconsin Tobacco Quitline Utilization by Southeastern Wisconsin Clinics
Study Start Date : September 2008
Primary Completion Date : August 2010
Study Completion Date : August 2011
Arms and Interventions

Arm Intervention/treatment
Experimental: Fax to Quit plus Enhanced Academic Detailing (F2Q + EAD)
Clinics in this group receive Fax to Quit materials and in person training from a Regional Outreach Specialist (ROS). The ROS also provides on-going training/technical assistance and performance feedback.
Other: Fax to Quit (F2Q)
Clinics in this group receive electronic and hard copies of all materials necessary for implementing Fax to Quit within their clinics.
Placebo Comparator: Fax to Quit alone
Clinics in this group receive Fax to Quit materials and can download materials from a website.
Other: Fax to Quit (F2Q)
Clinics in this group receive electronic and hard copies of all materials necessary for implementing Fax to Quit within their clinics.


Outcome Measures

Primary Outcome Measures :
  1. Number of Fax to Quit referrals [ Time Frame: One year following enrollment ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Adult (18 years of age or older)
  • Smoker seeking medical care from general practice (internal medicine) clinic (clinic enrolled in study)
  • Smoker motivated to make a quit attempt

Exclusion Criteria:

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00989755


Locations
United States, Wisconsin
Center for Tobacco Research and Intervention
Madison, Wisconsin, United States, 53711
Sponsors and Collaborators
University of Wisconsin, Madison
Investigators
Principal Investigator: Michael C Fiore, MD MPH MBA University of Wisconsin--CTRI
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: University of Wisconsin, Madison
ClinicalTrials.gov Identifier: NCT00989755     History of Changes
Other Study ID Numbers: M-2008-1335
First Posted: October 5, 2009    Key Record Dates
Last Update Posted: December 9, 2015
Last Verified: December 2015

Keywords provided by University of Wisconsin, Madison:
Tobacco dependence treatment in primary health care setting
Fax to Quit
Fax to Quit plus Enhanced Academic Detailing
Fax referral
Quitline